Metronidazol B. Braun

Metronidazole, the active ingredient in Metronidazol B. Braun, is a nitroimidazole antibiotic presented as a sterile solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal infections in adults and children. GNH USA supplies Metronidazol B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazol B. Braun is a nitroimidazole antibiotic used to manage infections caused by anaerobic microorganisms and selected protozoa. - Anaerobic bacterial infections: eradicates susceptible anaerobes and reduces infection severity. - Clostridioides difficile infection: helps control toxin‑producing C. difficile colitis. - Bacterial vaginosis: restores normal vaginal flora by targeting anaerobic pathogens. - Amebic liver abscess: eliminates Entamoeba histolytica organisms in hepatic tissue.

Metronidazol B. Braun may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools that may be self‑limiting. - Abdominal pain: cramping or discomfort in the abdomen. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Neutropenia: marked reduction in white blood cells.

Before using Metronidazol B. Braun, consider the following safety measures. - Renal impairment: adjust therapy in patients with reduced kidney function. - Hepatic dysfunction: monitor liver enzymes and use cautiously. - Alcohol consumption: avoid alcohol to prevent disulfiram‑like reactions. - Pregnancy and lactation: assess risk‑benefit, as safety data are limited. - Concomitant anticoagulants: monitor coagulation parameters for enhanced bleeding risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazol B. Braun can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, and tachycardia. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium serum levels, leading to toxicity. - CYP450 inducers (e.g., rifampin): reduce metronidazole plasma concentrations.

Moderate Interactions (Monitor Closely): - Phenytoin: may lower metronidazole levels. - Carbamazepine: may decrease efficacy of metronidazole. - Cimetidine: can increase metronidazole exposure. - Oral contraceptives: may reduce hormonal effectiveness, consider backup contraception.